Department of Tumor Biological Therapy

Yunnan Cancer Hospital, Kunming
肿瘤生物治疗中心 · Medical Oncology

Established in October 2005, this department integrates clinical care, teaching, and research. It treats malignant tumors of the lung, melanoma, breast, kidney, lymphatic system, stomach, colorectal region, digestive tract, urinary system, and blood. Treatment combines precision biological therapies, including immunotherapy, targeted therapy, and anti-angiogenesis, with radiation and chemotherapy. The unit operates a 50-bed clinical ward and a GMP-compliant cell production facility. Services include cell collection, immune cell preparation, storage, and immunophenotyping. Current translational clinical research involves Chimeric Antigen Receptor T-cell (CAR-T), Tumor-Infiltrating Lymphocytes (TIL), CIK, DC-CIK, and NK cell therapies.

What the department treats

Key facts

As described by the hospital.

Team

4 doctors listed, including 1 chief physicians. Its chief physicians have 4 first- or senior-author papers on PubMed since 2016.

Chief physicianClinical focusKey papers since 2016
Prof. Xicai Wang
王熙才 · Professor
Biological immunotherapy and chemotherapy for malignant tumors.4

Associate chief physicians

We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.

Not sure which specialist is right?

Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.

Get a specialist opinion